Sign in

CIK 0001936258 · Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. 6-K Event Report of Foreign Issuer
  2. UPLOAD Other SEC-generated Letter
  3. F-1 Offering Registration Statement for Certain Foreign Private Issuers
  4. 6-K Event Report of Foreign Issuer
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13D Stake Beneficial Ownership Report
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13D Stake Beneficial Ownership Report
  10. 20-F Report Annual and Transition Report of Foreign Private Issuers
  11. 6-K Event Report of Foreign Issuer
  12. CERT Other Certification
  13. 8-A12B Other Registration of Securities
  14. 8-A12B Other Registration of Securities
  15. 425 Deal Prospectus/Communication re Business Combination
  16. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  17. EFFECT Other Notice of Effectiveness
  18. 424B3 Offering Prospectus
  19. 425 Deal Prospectus/Communication re Business Combination
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 19 of 21 · 415 filings